.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Accenture
McKesson
Fish and Richardson
QuintilesIMS
UBS
Farmers Insurance
Moodys
Colorcon
Johnson and Johnson

Generated: September 23, 2017

DrugPatentWatch Database Preview

DEXMEDETOMIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Dexmedetomidine Hydrochloride, and when can generic versions of Dexmedetomidine Hydrochloride launch?

Dexmedetomidine Hydrochloride is a drug marketed by Accord Hlthcare, Sun Pharm Inds Inc, Hq Spclt Pharma, West-ward Pharms Int, Sandoz Inc, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Par Sterile Products, Luitpold Pharms Inc, Mylan Institutional, Akorn Inc, and Actavis Inc. and is included in twelve NDAs.

The generic ingredient in DEXMEDETOMIDINE HYDROCHLORIDE is dexmedetomidine hydrochloride. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dexmedetomidine hydrochloride profile page.

Summary for Tradename: DEXMEDETOMIDINE HYDROCHLORIDE

Patents:0
Applicants:12
NDAs:12
Suppliers / Packagers: see list11
Bulk Api Vendors: see list43
Clinical Trials: see list2,832
Patent Applications: see list92
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXMEDETOMIDINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DEXMEDETOMIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION204023-001Feb 9, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION205867-001Mar 17, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
SOLUTION;IV (INFUSION)206628-001Oct 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Akorn Inc
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION202585-001Nov 24, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION201072-001Sep 18, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION202126-001Aug 20, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
SOLUTION;IV (INFUSION)206628-002Oct 21, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Sandoz Inc
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION091465-001Jun 14, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION205046-001Apr 26, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Luitpold Pharms Inc
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION203773-001May 12, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Fuji
Chubb
Julphar
Healthtrust
AstraZeneca
Cipla
US Department of Justice
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot